Navigation Links
New Genes Found for Inflammatory Bowel Disease in Children
Date:8/31/2008

e easier to deliver as well as more customized to each patient."

The study team also found an association between ulcerative colitis and genes on the major histocompatiblity complex (MHC) on chromosome 6. The MHC is a large group of genes with important roles in the immune system, and this finding may help refine diagnostic techniques that would allow physicians to administer more specific therapies to their patients.

The Center for Pediatric Inflammatory Bowel Disease at Children's Hospital currently treats 1,400 children annually for IBD, and has one of the world's largest clinical research programs for IBD. The Center for Applied Genomics, directed by Hakonarson, is currently the largest pediatric genotyping program in the world. The Center's highly automated analytic equipment scans each DNA sample for over half a million genetic markers.

Financial support for the study came from the National Institutes of Health, the IBD Family Research Council, the Crohn's and Colitis Foundation of America, the Koss Foundation, the NIH General Clinical Research Center of the Medical College of Wisconsin, the Primary Children's Medical Center Foundation, the Edmunds Fund, the Heineman Foundation, the Cotswold Foundation, and The Children's Hospital of Philadelphia, which funded all genotyping performed in the study.

Baldassano's and Hakonarson's co-authors included Struan Grant, Ph.D., Jonathan Bradfield, Ph.D., David A. Piccoli, M.D., Petar Mamula, M.D., Robert Grundmeier, M.D., and Dimitri Monos, Ph.D., all of Children's Hospital. Other co-authors were Subra Kugathasan, M.D. (formerly of the Medical College of Wisconsin and currently at Emory University), who is co-first author with Baldassano; Stephen Guthery, M.D., of the University of Utah; Gitit Tomer, M.D., and Lee Denson, M.D., of Cincinnati Children's Hospital Medical Center; Salvatore Cucchiara, M.D., Ph.D., of Sapienza University, Rome, Italy; and Vito Annese, M.D., of "Casa Sollievo della
'/>"/>

SOURCE Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
2. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
3. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
4. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
5. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
6. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
9. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... CARROLLTON, Ga., Dec. 14 /PRNewswire/ ... that its flagship integrated EHR, Prime Suite ... conditionally CCHIT Certified(®) 2011 Ambulatory EHR, additionally ... with optional Advanced Reporting. Greenway,s Prime Suite ... two new 2011 certification designations offered by ...
(Date:12/14/2009)... 14 Environmental health advocates hope that ... health hazards of bisphenol A (BPA), a synthetic ... harm and other illnesses, in time for Christmas. ... , staff scientist, Natural Resources Defense Council ... for medical advice, FDA must rely on the ...
(Date:12/14/2009)... GeoInvesting.com, we have been tracking Tianyin Pharmaceuticals (NYSE Amex: ... hang up had been with the potential dilution from ... income guidance of $11.3 million represents a 43.0% increase ... million, the increase in shares poses some uncertainty regarding ... the share price and the Treasury method of accounting ...
Breaking Medicine Technology:Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Fifth Annual Games for Health Conference Kicks Off in Boston 48612 1Fifth Annual Games for Health Conference Kicks Off in Boston 48612 2Fifth Annual Games for Health Conference Kicks Off in Boston 48612 3Fifth Annual Games for Health Conference Kicks Off in Boston 48612 4SmallCapSentinel com Releases Market Actives List for JAZZ MEXP C SAY GOOG AAPL 48610 1SmallCapSentinel com Releases Market Actives List for JAZZ MEXP C SAY GOOG AAPL 48610 2Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis 48608 1Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis 48608 2
... Rockwell Medical,Technologies, Inc. (Nasdaq: RMTI ), ... and specialty pharmaceuticals focused on the end-,stage-renal-disease ... begun dosing,patients in its Phase IIb Dose-Ranging ... Company,s physiological iron-maintenance-therapy,drug. The Phase IIb ...
... ImClone Systems Incorporated,(Nasdaq: IMCL ) and ... announced,that the U.S. Food and Drug Administration (FDA) ... labeling to include overall survival,data as a single ... cancer (mCRC) patients after,failure of both irinotecan- and ...
Other Medicine Technology:Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 2Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 3Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7
(Date:12/14/2009)... Canada for 13 years under government controlled health care, before moving ... In speaking engagements and in his new book, Health Reform: The ... of such a system and its threat to real health care! ... ... Kurisko , a diagnostic radiologist from Minnesota, warns Americans not to ...
(Date:12/14/2009)... to Stemming Tide of Tens of Thousands of ... Dec. 14 Legislation approved by Congress ... be crucial in helping to reduce tens of ... year in the United States, the National ... The provision was included in the FY 2010 ...
(Date:12/14/2009)... been treated, hadn,t spread, study finds , , MONDAY, Dec. ... risk of death in male colon cancer survivors, researchers ... included 668 men who,d been treated for stage I, ... not spread (nonmetastatic cancer). Every two years, the men ... cancer and disease diagnoses, as well as their physical ...
(Date:12/14/2009)... -- Type 2 diabetes and obesity are linked to ... studies suggested that insulin glargine (a synthetic insulin preparation ... with a higher risk of certain cancers than other ... studies were unable to control for important factors such ... , On the other hand, a large randomized trial ...
(Date:12/14/2009)... Biopsy , ... Newport News, VA ... that the U.S. Food and Drug Administration (FDA) has granted ... guidance. , , ,GammaLMc® is a complementary technology to ... (GL) system will help doctors accurately locate breast lesions and ...
Breaking Medicine News(10 mins):Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2
... working from separate laboratory benches across the country has discovered ... blood. The technique, which holds promise for disinfecting blood ... lasting just fractions of a second. , Johns Hopkins University ... in the park with his father that the idea was ...
... EDISON, N.J., Sept. 4 Marlabs, Inc. has ... Book of Outsourcing list of Top 10 BPO,healthcare ... 117,000 invitations were issued to outsourcing users and,decision ... global outsourcing vendors. Marlabs,s CEO Siby Vadakekkara ...
... to Benefit St. Jude Children,s Research Hospital(R), ... leading specialty,retailer of furniture, bedding and home furnishings, ... celebrity signed chair sold on,charitybuzz.com for $1200. Backstage ... Accent Chair was signed by 39 celebrities including,Elisabeth ...
... rate when parents took part in therapy , , TUESDAY, Sept. ... in the treatment of teens with bulimia, a new study ... program, the percentage of teens able to abstain from the ... have often been seen as part of the problem, rather ...
... Abbott (NYSE: ABT ),will present at the Bear ... Thomas C. Freyman, executive vice president,finance and chief financial ... 8:30 a.m. Central time. A live audio webcast ... Web site at http://www.abbottinvestor.com . An,archived edition of ...
... Services ... Divisions, ... food and facilities management services in North,America, announced today the appointment ... Health Care Services. Connolly fills,the position vacated by George Chavel, who ...
Other Medicine News:Health News:Laser blasts viruses in blood 2Health News:Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 2Health News:Celebrity Seating Only! Levitz Chair Signed by 39 Daytime Stars Sells for $1200 on Charitybuzz.com 2Health News:Parental Involvement Key to Battling Bulimia 2Health News:Parental Involvement Key to Battling Bulimia 3Health News:Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO 2
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Triad Plus BZK ... Chloride solution and are ... Benzalkonium Chloride (BZK) may ... gentle cleansing solution is ...
... are saturated with a 10% Povidone Iodine, ... Povidone Iodine is virtually non-irritating to skin, ... non-staining to the skin or natural fabrics. ... contact; they are sturdy tools for removing ...
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick....
Medicine Products: